Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

BACKGROUND: Long-acting antipsychotic therapy may be best suited for patients in the early stage of schizophrenia, when the most can be done before disease progression associated with poor adherence occurs. We explored the patterns of use of once-monthly paliperidone palmitate (PP1M), concomitant me...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychiatr Dis Treat
Autori principali: Emsley, Robin, Hargarter, Ludger, Bergmans, Paul, Uglešić, Boran, Sengül, Abdullah Cem, Petralia, Antonino, Khannanova, Angelina, Cherubin, Pierre, Schreiner, Andreas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587220/
https://ncbi.nlm.nih.gov/pubmed/28919757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S142634
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi